Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qianlieweitong granules in chronic prostatitis type III
CTR20130181Phase 2Completed
- Sponsor
- Jilin Province Innovative Pharmaceutical Public Service Platform
- Start
- Jan 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of qianlieweitong granules in chronic prostatitis (CP), sponsored by Jilin Province Innovative Pharmaceutical Public Service Platform. Started Jan 2014; status: completed.
02
Drugs
qianlieweitong granules
03
Conditions
chronic prostatitis (CP)
Beyond the preview
Go deeper on CTR20130181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130181.